Do SGLT2 inhibitors increase the risk of amputation? Make haste slowly

Eur Heart J. 2021 May 7;42(18):1739-1741. doi: 10.1093/eurheartj/ehaa1022.

Authors

Charalambos Vlachopoulos¹, Dimitrios Terentes-Printzios¹, Konstantinos Tsioufis¹

Affiliation

¹ First Department of Cardiology, Hippokration Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

PMID: 33374009
DOI: 10.1093/eurheartj/ehaa1022

No abstract available

Publication types

Editorial
Comment

MeSH terms

Amputation, Surgical
Diabetes Mellitus, Type 2* / drug therapy
Glucose
Humans
Hypoglycemic Agents / adverse effects
Peripheral Arterial Disease*
Sodium
Sodium-Glucose Transporter 2 Inhibitors* / adverse effects

Substances

Hypoglycemic Agents
Sodium-Glucose Transporter 2 Inhibitors
Sodium
Glucose